Press room

1st May 2009
Natural products drug company Hypha Discovery signs deal with Domainex to support its research programme on novel oncology drugs
1st March 2009
Domainex announced a collaboration on exciting drug discovery programmes with the Breakthrough Breast Cancer Research Centre and The Institute of Cancer Research to identify and develop inhibitors of two recently validated breast cancer targets, tankyrase and IKK-epsilon.
1st January 2009
Domainex will be sponsoring and presenting at PEGS - The Protein Expression Summit, which will be held in Boston MA, 6-10 April 2009.
1st May 2008
Professor Laurence Pearl, founder and CSO of Domainex, elected a Fellow of the Royal Society. Prof. Laurence Pearl's New Fellow's Seminar - Structural Biology of HSP90
1st July 2007
New drug discovery company Domainex and the leading global biopharmaceutical company UCB have successfully completed their first collaborative project with the creation of a particularly elusive target protein construct.